Home › Cancro del polmone non a piccole cellule › Illinois › Waukegan
Studi clinici su Cancro del polmone non a piccole cellule a Waukegan, IL
16 studi su Cancro del polmone non a piccole cellule cercano partecipanti presso sedi a Waukegan e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
In reclutamentoFase 3
- AMG Libertyville - Oncology, Libertyville · a 8 mi di distanza
- Condell Memorial Hospital, Libertyville · a 8 mi di distanza
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
In reclutamentoFase 3
- Northwestern Medicine Lake Forest Hospital, Lake Forest · a 7 mi di distanza
- Northwestern Medicine Grayslake Outpatient Center, Grayslake · a 10 mi di distanza
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
In reclutamentoFase 2
- City of Hope Chicago, Zion · a 6 mi di distanza
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
In reclutamentoFase 3
- Advocate Medical Group - Libertyville Oncology, Libertyville · a 8 mi di distanza
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
In reclutamentoFase 3
- Captain James A. Lovell Federal Health Care Center, North Chicago · a 3 mi di distanza
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
In reclutamentoFase 3
- City of Hope® Cancer Center Chicago, Zion · a 6 mi di distanza
Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic Alterations
In reclutamentoFase 3
- Research Site, Zion · a 6 mi di distanza
Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung Cancer
In reclutamentoFase 3
- Research Site, North Chicago · a 3 mi di distanza
Radiotherapy to Block Oligoprogression In Metastatic Non-Small-Cell Lung Cancer
In reclutamentoFase 3
- Northwestern Medicine Lake Forest Hospital, Lake Forest · a 7 mi di distanza
- Northwestern Medicine Grayslake Outpatient Center, Grayslake · a 10 mi di distanza
LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC
In reclutamentoFase 3
- Cancer Treatment Centers of America (CTCA), Zion · a 6 mi di distanza
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
In reclutamentoFase 2
- Northwestern Medicine Lake Forest Hospital, Lake Forest · a 7 mi di distanza
- AMG Libertyville - Oncology, Libertyville · a 8 mi di distanza
- Condell Memorial Hospital, Libertyville · a 8 mi di distanza
- e altri 1
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)
In reclutamentoFase 2
- Northwestern Medicine Lake Forest Hospital, Lake Forest · a 7 mi di distanza
- AMG Libertyville - Oncology, Libertyville · a 8 mi di distanza
- Condell Memorial Hospital, Libertyville · a 8 mi di distanza
- e altri 1
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
In reclutamentoFase 2/3
- Northwestern Medicine Lake Forest Hospital, Lake Forest · a 7 mi di distanza
- AMG Libertyville - Oncology, Libertyville · a 8 mi di distanza
- Condell Memorial Hospital, Libertyville · a 8 mi di distanza
- e altri 1
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
In reclutamentoFase 2
- Northwestern Medicine Lake Forest Hospital, Lake Forest · a 7 mi di distanza
- Northwestern Medicine Grayslake Outpatient Center, Grayslake · a 10 mi di distanza
Immunotherapy Biomarkers to Predict First-line PD(L)1-based Immunotherapy Response and Selection of Second-line Treatment in Stage IIIB-IV Non-small Cell Lung Cancer, IMMUNO-BIOMAP Trial
In reclutamentoFase 2
- City of Hope at Chicago, Zion · a 6 mi di distanza
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
In reclutamentoStudio osservazionale
- AMG Libertyville - Oncology, Libertyville · a 8 mi di distanza
- Condell Memorial Hospital, Libertyville · a 8 mi di distanza
Studi su Cancro del polmone non a piccole cellule in altre città
- Houston, TX145 studi
- New York City, NY121 studi
- Arlington, VA104 studi
- Nashville, TN97 studi
- Boston, MA90 studi
- Los Angeles, CA87 studi
- St. Louis, MO73 studi
- Chicago, IL61 studi
- Baltimore, MD60 studi
- San Antonio, TX59 studi
- Columbus, OH57 studi
- Washington, DC55 studi
Altri studi a Waukegan
- Cancro ai polmoni16 studi
- Cancro al seno12 studi
- Colite ulcerosa7 studi
- Cancro al rene (carcinoma a cellule renali)7 studi
- Cancro ovarico6 studi
- Cancro metastatico6 studi
- Carcinoma a cellule squamose della testa e del collo6 studi
- Cancro colorettale6 studi
- Cancro alla prostata6 studi
- Melanoma5 studi
- Leucemia mieloide acuta5 studi
- Malattia di Crohn5 studi
Fonte: ClinicalTrials.gov, dati recuperati il 6 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.